TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34255369 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34290036 — Surrogate Endpoint (SUR): Blood pressure
Study 32047237 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 34999928 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33851461 — Surrogate Endpoint (SUR): Blood pressure
Study 33497362 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 33497362 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33497362 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCR2 mRNA
Genes: CCR2; CMKBR2
Study 33497362 — Predictive Biomarker (PRD): GAS6 mRNA
Genes: GAS6; AXLLG
Study 33497362 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35192610 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34287833 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 32799922 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study 36817806 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 35534916 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 35534916 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 36305963 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32778150 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33992277 — Predictive Biomarker (PRD): PDLIM4 mRNA
Genes: PDLIM4; RIL
Study 33167921 — Predictive Biomarker (PRD): TAPBP mRNA
Genes: TAPBP; NGS17; TAPA
Study 32840417 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 35120566 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 33740394 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35896211 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35896211 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32185203 — Surrogate Endpoint (SUR): Bone mineral density
Study 34229299 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study 34229299 — Predictive Biomarker (PRD): RAC1 mRNA
Genes: RAC1; TC25; MIG5
Study 34229299 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 34229299 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study 34229299 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 36327426 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36327426 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 32211803 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 32211803 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32211803 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study 36855010 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 34818575 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35345521 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 32336695 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33608144 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34125267 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 33814268 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study 36258845 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 32072617 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32072617 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 35886043 — Predictive Biomarker (PRD): CDH9 mRNA
Genes: CDH9
Study 35886043 — Surrogate Endpoint (SUR): Blood pressure
Study 34746425 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 34100082 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34880372 — Surrogate Endpoint (SUR): Serum creatinine
Study 34419414 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 35289915 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35816900 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35384257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34033146 — Surrogate Endpoint (SUR): Bone mineral density
Study 32418145 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32794567 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36102212 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 36102212 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 32692358 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 33262411 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 33157330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33084406 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33086749 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33486138 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 36202649 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 32938569 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35745100 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 33858395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33858395 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32712173 — Surrogate Endpoint (SUR): Blood pressure
Study 34803132 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34411597 — Safety Biomarker (SAF): Hyaluronic acid
Study 32975679 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 33276944 — Predictive Biomarker (PRD): IGSF11 mRNA
Genes: IGSF11; BTIGSF; CXADRL1; VSIG3
Study 32069126 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 33414377 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 33414377 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32609532 — Surrogate Endpoint (SUR): Blood pressure
Study 32609532 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34622669 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 32629662 — Surrogate Endpoint (SUR): Blood pressure
Study 32930627 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32930627 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32930627 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33397121 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 33615395 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33615395 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 33615395 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33615395 — Predictive Biomarker (PRD): SLC6A19 mRNA
Genes: SLC6A19; B0AT1
Study 33615395 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33142505 — Predictive Biomarker (PRD): SCARB1 mRNA
Genes: SCARB1; CD36L1; CLA1
Study 33142505 — Predictive Biomarker (PRD): VLDLR mRNA
Genes: VLDLR
Study 33142505 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33142505 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33142505 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35172663 — Surrogate Endpoint (SUR): Sperm parameters
Study 32785972 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35902979 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 33301579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32035222 — Predictive Biomarker (PRD): GDF11 mRNA
Genes: GDF11; BMP11
Study 32035222 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Growth/differentiation factor 8
Genes: MSTN; GDF8
Study 34891224 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 33559445 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 34251865 — Surrogate Endpoint (SUR): Blood pressure
Study 35503997 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study 34736367 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34493219 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33944622 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 33944622 — Predictive Biomarker (PRD): SLC6A2 mRNA
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study 34331964 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 34331964 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 33795788 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34158437 — Surrogate Endpoint (SUR): Probing pocket depth
Study 36817351 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36817351 — Surrogate Endpoint (SUR): Blood pressure
Study 36817351 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36817351 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33961534 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 36200477 — Surrogate Endpoint (SUR): Blood pressure
Study 36200477 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32321880 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 34928698 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32930113 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35279508 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 35963234 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32861144 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 32861144 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33300437 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34046741 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33858369 — Surrogate Endpoint (SUR): Serum creatinine
Study 32717421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 33517703 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 34315331 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34315331 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 33227175 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33227175 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34254966 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 33858620 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32059083 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 33008422 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 34122682 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 36201354 — Monitoring Biomarker (MOI): HBV DNA
Study 35985037 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 32417976 — Surrogate Endpoint (SUR): Blood pressure
Study 35654771 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35654771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35654771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32568732 — Surrogate Endpoint (SUR): Bone mineral density
Study 35303909 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 35303909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study 32251265 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 33851448 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33851448 — Surrogate Endpoint (SUR): Blood pressure
Study 32492712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32492712 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36049047 — Surrogate Endpoint (SUR): Bacterial count
Study 32568198 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 36173561 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 36173561 — Surrogate Endpoint (SUR): Blood pressure
Study 32459651 — Surrogate Endpoint (SUR): Blood pressure
Study 35998021 — Predictive Biomarker (PRD): GK mRNA
Genes: GK
Study 34172261 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34983144 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 36175917 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34243086 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 34243086 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34243086 — Surrogate Endpoint (SUR): Blood pressure
Study 34253560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34253560 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 33742064 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 35275751 — Safety Biomarker (SAF): Coagulation factor Va
Genes: F5
Study 33989559 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35434257 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33859386 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32005066 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32294620 — Surrogate Endpoint (SUR): Blood pressure
Study 36286665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36286665 — Safety Biomarker (SAF): Interleukin 1
Study 36286665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32356505 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32311799 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33023430 — Surrogate Endpoint (SUR): Blood pressure
Study 33023430 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32040959 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33427559 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 33427559 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 33427559 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 33427559 — Surrogate Endpoint (SUR): Serum calcium
Study 36183738 — Predictive Biomarker (PRD): SLC12A3 mRNA
Genes: SLC12A3; NCC; TSC
Study 32179516 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 32179516 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33331206 — Predictive Biomarker (PRD): FFAR1 mRNA
Genes: FFAR1; GPR40
Study 32428844 — Predictive Biomarker (PRD): DHODH mRNA
Genes: DHODH
Study 35698162 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 35798138 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 35984704 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study 35984704 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 32728820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32728820 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35441440 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35441440 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 36007937 — Surrogate Endpoint (SUR): Blood pressure
Study 33998345 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 33971837 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 36001314 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36001314 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36001314 — Predictive Biomarker (PRD): Hormone receptor
Study 32144493 — Surrogate Endpoint (SUR): Blood pressure
Study 33471429 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34057130 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34057130 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 34057130 — Surrogate Endpoint (SUR): Blood pressure
Study 33370348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35099050 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33055588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 33055588 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35851031 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34092822 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study 35254888 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 32461289 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32461289 — Surrogate Endpoint (SUR): Serum creatinine
Study 35361646 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35361646 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33431716 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33431716 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36423863 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 36226241 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 36226241 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32471657 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 34922038 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32874061 — Monitoring Biomarker (MOI): HBV DNA
Study 35001638 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32560746 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36433662 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33836878 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 33836878 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 32218096 — Surrogate Endpoint (SUR): Serum creatinine
Study 35062886 — Surrogate Endpoint (SUR): Serum creatinine
Study 33462653 — Surrogate Endpoint (SUR): Bone mineral density
Study 33340238 — Surrogate Endpoint (SUR): Serum creatinine
Study 33340238 — Surrogate Endpoint (SUR): Blood pressure
Study 36374501 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 36266534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36266534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36266534 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32866850 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 33152450 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33371056 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 34233350 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 32737450 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study 33151615 — Safety Biomarker (SAF): Reactive oxygen species
Study 32036959 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study 32036959 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32036959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33493453 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 32665529 — Surrogate Endpoint (SUR): Bone mineral density
Study 35023284 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33582019 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33582019 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 36261538 — Surrogate Endpoint (SUR): Bone mineral density
Study 33901921 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35059803 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study 32034255 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32034255 — Safety Biomarker (SAF): Interleukin 1